Hypertension in Northern Angola: prevalence, associated factors, awareness, treatment and control

Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is ne...

Full description

Saved in:
Bibliographic Details
Published inBMC public health Vol. 13; no. 1; p. 90
Main Authors Pires, João E, Sebastião, Yuri V, Langa, António J, Nery, Susana V
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 31.01.2013
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola. A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected. Prevalence of hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension. Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease.
AbstractList Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola. A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected. Prevalence of hypertension (systolic blood pressure [greater than or equai to]140 mmHg and/or diastolic blood pressure [greater than or equai to]90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension. Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease.
Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola.BACKGROUNDSeventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola.A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected.METHODSA community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected.Prevalence of hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension.RESULTSPrevalence of hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension.Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease.CONCLUSIONSOur survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease.
Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola. A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected. Prevalence of hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension. Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease.
Doc number: 90 Abstract Background: Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola. Methods: A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected. Results: Prevalence of hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension. Conclusions: Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease.
Background Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola. Methods A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected. Results Prevalence of hypertension (systolic blood pressure [greater than or equai to]140 mmHg and/or diastolic blood pressure [greater than or equai to]90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension. Conclusions Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease. Keywords: Angola, DSS, Hypertension, Prevalence, Epidemiological transition
Background: Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola. Methods: A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18-40 and 41-64 years old), was selected. Results: Prevalence of hypertension (systolic blood pressure > or =140 mmHg and/or diastolic blood pressure > or =90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension. Conclusions: Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease.
ArticleNumber 90
Audience Academic
Author Nery, Susana V
Sebastião, Yuri V
Langa, António J
Pires, João E
AuthorAffiliation 1 CISA Project (Health Research Center in Angola), Rua Direita do Caxito, Caxito, Bengo, Angola
AuthorAffiliation_xml – name: 1 CISA Project (Health Research Center in Angola), Rua Direita do Caxito, Caxito, Bengo, Angola
Author_xml – sequence: 1
  givenname: João E
  surname: Pires
  fullname: Pires, João E
– sequence: 2
  givenname: Yuri V
  surname: Sebastião
  fullname: Sebastião, Yuri V
– sequence: 3
  givenname: António J
  surname: Langa
  fullname: Langa, António J
– sequence: 4
  givenname: Susana V
  surname: Nery
  fullname: Nery, Susana V
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23363805$$D View this record in MEDLINE/PubMed
BookMark eNqNks9rFTEQxxep2B969iYLXjx022TzYzcehEepVih60XOYTWZfU3aTZ5JX6X9vltZnWxQkgQyTz3wZvjOH1Z4PHqvqNSUnlPbylPKONi0XfUNZo8iz6mCX2XsQ71eHKV0TQrtetC-q_ZYxyXoiDiq4uN1gzOiTC752vv4SYr7C6OuVX4cJ3tebiDcwoTd4XENKwTjIaOsRTA4xldxPiOgxlTBHhDyjzzV4W5vgcwzTy-r5CFPCV_fvUfX94_m3s4vm8uunz2ery8aIluaG8wGtGTqBVirVMU4USgEDt8CGQTKirALLDQVlJSeC0pbY0fbtoDo5MMGOqg93upvtMBep0kaESW-imyHe6gBOP_7x7kqvw41mQineqiLw7l4ghh9bTFnPLhmcJvAYtklT1rKeynL_A12cJpT1BX37BL0O2-iLEwsllCiD6P5Q62K1dn4MpUWziOqVYFy2XApWqJO_UOVYnF2xG0dX8o8K3jz0ZGfG7_kX4PQOMDGkFHHcIZToZcP0skN62aHSrlakVIgnFcZlyG4ZNrjpn3W_AEin0pw
CitedBy_id crossref_primary_10_1590_2177_9465_ean_2021_0321pt
crossref_primary_10_70360_rccse__v_62
crossref_primary_10_1136_bmjopen_2016_014349
crossref_primary_10_1016_j_amsu_2020_04_017
crossref_primary_10_1186_s12889_016_2759_9
crossref_primary_10_1186_s12889_016_3365_6
crossref_primary_10_1371_journal_pone_0104300
crossref_primary_10_3389_ijph_2023_1606428
crossref_primary_10_3390_healthcare9080964
crossref_primary_10_1371_journal_pone_0193494
crossref_primary_10_1093_ije_dyx279
crossref_primary_10_1016_j_ijid_2017_05_011
crossref_primary_10_1080_16549716_2017_1321279
crossref_primary_10_2147_RMHP_S432943
crossref_primary_10_1093_ije_dyx072
crossref_primary_10_1155_2018_8307591
crossref_primary_10_1371_journal_pone_0188586
crossref_primary_10_1371_journal_pone_0219377
crossref_primary_10_1186_s12872_019_01273_7
crossref_primary_10_1177_20503121221104442
crossref_primary_10_1590_2177_9465_ean_2021_0321en
crossref_primary_10_4137_CMC_S39561
crossref_primary_10_2147_IBPC_S432251
crossref_primary_10_4102_phcfm_v10i1_1758
crossref_primary_10_1186_1471_2458_14_386
crossref_primary_10_1186_s12889_022_14026_7
crossref_primary_10_1111_tmi_12443
crossref_primary_10_3917_spub_222_0289
crossref_primary_10_1177_20503121211024519
crossref_primary_10_1186_s12889_015_2546_z
crossref_primary_10_3389_fcvm_2024_1403214
crossref_primary_10_4103_aam_aam_20_20
crossref_primary_10_1186_1471_2261_13_54
crossref_primary_10_1161_HYPERTENSIONAHA_114_04394
crossref_primary_10_1371_journal_pone_0215500
crossref_primary_10_1186_1471_2458_14_893
crossref_primary_10_1155_2020_9032476
crossref_primary_10_1111_jch_12863
crossref_primary_10_1371_journal_pone_0218052
crossref_primary_10_1038_jhh_2017_18
crossref_primary_10_1371_journal_pone_0205985
crossref_primary_10_1111_jch_13873
crossref_primary_10_1097_HJH_0000000000002165
crossref_primary_10_1097_HJH_0000000000001312
crossref_primary_10_1371_journal_pone_0192942
crossref_primary_10_2174_1874944501710010148
crossref_primary_10_4236_jbm_2022_105017
crossref_primary_10_1186_s12889_016_3008_y
crossref_primary_10_1007_s40292_015_0114_3
crossref_primary_10_1159_000381453
crossref_primary_10_1186_s12889_016_3926_8
Cites_doi 10.1161/HYPERTENSIONAHA.107.093336
10.1097/00004872-200311000-00002
10.1097/01.mbp.0000209078.17246.34
10.1097/00004872-200018020-00003
10.1016/j.jacc.2012.04.026
10.1161/01.HYP.0000126176.03319.d8
10.1371/journal.pone.0033189
10.1097/00004872-200303000-00016
10.1016/j.jacc.2008.08.049
10.1038/sj.jhh.1001924
10.1097/HJH.0b013e3283282f65
10.1016/S0140-6736(05)70151-3
10.1186/1471-2458-10-569
10.1038/oby.2002.141
10.1080/14034940500204506
10.1038/sj.jhh.1001923
10.1161/HYPERTENSIONAHA.109.132423
10.1097/HJH.0b013e328346995d
ContentType Journal Article
Copyright COPYRIGHT 2013 BioMed Central Ltd.
2013 Pires et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright ©2013 Pires et al.; licensee BioMed Central Ltd. 2013 Pires et al.; licensee BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2013 BioMed Central Ltd.
– notice: 2013 Pires et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: Copyright ©2013 Pires et al.; licensee BioMed Central Ltd. 2013 Pires et al.; licensee BioMed Central Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T2
7X7
7XB
88E
8C1
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AN0
ATCPS
AZQEC
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
L6V
M0S
M1P
M7S
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
7X8
7U1
5PM
DOI 10.1186/1471-2458-13-90
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
ProQuest Health & Medical Collection
Medical Database
Engineering Database
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering collection
Environmental Science Collection
MEDLINE - Academic
Risk Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Engineering Database
ProQuest Public Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
Environmental Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Risk Abstracts
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Publicly Available Content Database

Risk Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1471-2458
EndPage 90
ExternalDocumentID PMC3599429
2914053531
A534624653
23363805
10_1186_1471_2458_13_90
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Angola
Africa
GeographicLocations_xml – name: Angola
– name: Africa
GroupedDBID ---
0R~
23N
2WC
2XV
4.4
44B
53G
5VS
6J9
6PF
7X7
7XC
88E
8C1
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABJCF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AN0
AOIJS
ATCPS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BGLVJ
BHPHI
BMC
BNQBC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
IPNFZ
ITC
KQ8
L6V
M1P
M48
M7S
M~E
O5R
O5S
OK1
OVT
P2P
PATMY
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RBZ
RIG
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7T2
7XB
8FK
AZQEC
C1K
DWQXO
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
7U1
5PM
ID FETCH-LOGICAL-c521t-44bedcb75ed69973409e65ab4da3bb6309d9ad4c1a9d64051120dfd82b976b353
IEDL.DBID M48
ISSN 1471-2458
IngestDate Thu Aug 21 14:13:12 EDT 2025
Mon Jul 21 11:17:55 EDT 2025
Fri Jul 11 03:39:21 EDT 2025
Fri Jul 25 10:49:20 EDT 2025
Tue Jun 17 22:05:30 EDT 2025
Tue Jun 10 21:03:09 EDT 2025
Thu Apr 03 07:03:48 EDT 2025
Thu Apr 24 22:50:48 EDT 2025
Tue Jul 01 04:09:29 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License http://www.springer.com/tdm
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c521t-44bedcb75ed69973409e65ab4da3bb6309d9ad4c1a9d64051120dfd82b976b353
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/1471-2458-13-90
PMID 23363805
PQID 1315956387
PQPubID 44782
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3599429
proquest_miscellaneous_1323816816
proquest_miscellaneous_1317850138
proquest_journals_1315956387
gale_infotracmisc_A534624653
gale_infotracacademiconefile_A534624653
pubmed_primary_23363805
crossref_primary_10_1186_1471_2458_13_90
crossref_citationtrail_10_1186_1471_2458_13_90
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-01-31
PublicationDateYYYYMMDD 2013-01-31
PublicationDate_xml – month: 01
  year: 2013
  text: 2013-01-31
  day: 31
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC public health
PublicationTitleAlternate BMC Public Health
PublicationYear 2013
Publisher BioMed Central Ltd
BioMed Central
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
References World Health Organization (5061_CR16) 2000; 894
T Puoane (5061_CR27) 2002; 10
J Mufunda (5061_CR19) 2006; 20
M Pereira (5061_CR6) 2009; 27
World Health Organization (5061_CR2) 2009
Instituto Nacional de Estatística (5061_CR13) 2008
PM Kearney (5061_CR5) 2005; 365
JF Wamala (5061_CR25) 2009; 9
JA Topouchian (5061_CR15) 2006; 11
JC Sousa-Figueiredo (5061_CR12) 2012; 7
W Mathenge (5061_CR24) 2010; 10
R Edwards (5061_CR26) 2000; 18
N Ng (5061_CR8) 2006; 34
C Agyemang (5061_CR21) 2006; 24
JA Whitworth (5061_CR28) 2003; 21
FP Cappuccio (5061_CR22) 2004; 43
5061_CR14
5061_CR7
5061_CR11
J Addo (5061_CR4) 2007; 50
5061_CR17
F Guo (5061_CR20) 2012; 60
World Health Organization (5061_CR1) 2010
R Joshi (5061_CR23) 2008; 52
A Damasceno (5061_CR18) 2009; 54
P Bovet (5061_CR29) 2003; 21
World Health Organization (5061_CR9) 2011
5061_CR10
M Twagirumukiza (5061_CR3) 2011; 29
14597836 - J Hypertens. 2003 Nov;21(11):1983-92
21540748 - J Hypertens. 2011 Jul;29(7):1243-52
22493664 - PLoS One. 2012;7(4):e33189
16581713 - Scand J Public Health. 2006;34(2):199-208
10694181 - J Hypertens. 2000 Feb;18(2):145-52
16151443 - J Hum Hypertens. 2006 Jan;20(1):59-65
15037552 - Hypertension. 2004 May;43(5):1017-22
19038678 - J Am Coll Cardiol. 2008 Dec 2;52(23):1817-25
20860807 - BMC Public Health. 2010;10:569
11234459 - World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
16702826 - Blood Press Monit. 2006 Jun;11(3):165-71
12640244 - J Hypertens. 2003 Mar;21(3):509-17
19470872 - Hypertension. 2009 Jul;54(1):77-83
22796254 - J Am Coll Cardiol. 2012 Aug 14;60(7):599-606
12376585 - Obes Res. 2002 Oct;10(10):1038-48
20589143 - Afr Health Sci. 2009 Sep;9(3):153-60
15652604 - Lancet. 2005 Jan 15-21;365(9455):217-23
17954720 - Hypertension. 2007 Dec;50(6):1012-8
19402221 - J Hypertens. 2009 May;27(5):963-75
16121199 - J Hum Hypertens. 2006 Jan;20(1):67-71
References_xml – volume: 50
  start-page: 1012
  year: 2007
  ident: 5061_CR4
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.107.093336
– volume: 21
  start-page: 1983
  year: 2003
  ident: 5061_CR28
  publication-title: J Hypertens
  doi: 10.1097/00004872-200311000-00002
– volume-title: Non comunicable diseases country profiles
  year: 2011
  ident: 5061_CR9
– volume: 894
  start-page: 1
  year: 2000
  ident: 5061_CR16
  publication-title: World Health Organ Tech Rep Ser
– volume: 11
  start-page: 165
  year: 2006
  ident: 5061_CR15
  publication-title: Blood Press Monit
  doi: 10.1097/01.mbp.0000209078.17246.34
– volume: 18
  start-page: 145
  year: 2000
  ident: 5061_CR26
  publication-title: J Hypertens
  doi: 10.1097/00004872-200018020-00003
– volume: 60
  start-page: 599
  year: 2012
  ident: 5061_CR20
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2012.04.026
– volume-title: Global health risks: mortality and burden of disease attributable to selected major risks
  year: 2009
  ident: 5061_CR2
– ident: 5061_CR11
– volume: 43
  start-page: 1017
  year: 2004
  ident: 5061_CR22
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000126176.03319.d8
– volume: 9
  start-page: 153
  year: 2009
  ident: 5061_CR25
  publication-title: Afr Health Sci
– volume: 7
  start-page: e33189
  year: 2012
  ident: 5061_CR12
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0033189
– ident: 5061_CR17
– volume: 21
  start-page: 509
  year: 2003
  ident: 5061_CR29
  publication-title: J Hypertens
  doi: 10.1097/00004872-200303000-00016
– volume: 52
  start-page: 1817
  year: 2008
  ident: 5061_CR23
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2008.08.049
– ident: 5061_CR7
– volume-title: Manual de Instruções do Inquiridor
  year: 2008
  ident: 5061_CR13
– volume: 20
  start-page: 59
  year: 2006
  ident: 5061_CR19
  publication-title: J Hum Hypertens
  doi: 10.1038/sj.jhh.1001924
– volume: 27
  start-page: 963
  year: 2009
  ident: 5061_CR6
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e3283282f65
– volume: 365
  start-page: 217
  year: 2005
  ident: 5061_CR5
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)70151-3
– volume: 10
  start-page: 569
  year: 2010
  ident: 5061_CR24
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-10-569
– volume: 10
  start-page: 1038
  year: 2002
  ident: 5061_CR27
  publication-title: Obes Res
  doi: 10.1038/oby.2002.141
– volume-title: Global status report on noncommunicable diseases
  year: 2010
  ident: 5061_CR1
– ident: 5061_CR10
– volume: 34
  start-page: 199
  year: 2006
  ident: 5061_CR8
  publication-title: Scand J Public Health
  doi: 10.1080/14034940500204506
– ident: 5061_CR14
– volume: 24
  start-page: 67
  year: 2006
  ident: 5061_CR21
  publication-title: J Hum Hypertens
  doi: 10.1038/sj.jhh.1001923
– volume: 54
  start-page: 77
  year: 2009
  ident: 5061_CR18
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.109.132423
– volume: 29
  start-page: 1243
  year: 2011
  ident: 5061_CR3
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e328346995d
– reference: 12640244 - J Hypertens. 2003 Mar;21(3):509-17
– reference: 19470872 - Hypertension. 2009 Jul;54(1):77-83
– reference: 15037552 - Hypertension. 2004 May;43(5):1017-22
– reference: 16581713 - Scand J Public Health. 2006;34(2):199-208
– reference: 21540748 - J Hypertens. 2011 Jul;29(7):1243-52
– reference: 20860807 - BMC Public Health. 2010;10:569
– reference: 22493664 - PLoS One. 2012;7(4):e33189
– reference: 12376585 - Obes Res. 2002 Oct;10(10):1038-48
– reference: 14597836 - J Hypertens. 2003 Nov;21(11):1983-92
– reference: 17954720 - Hypertension. 2007 Dec;50(6):1012-8
– reference: 20589143 - Afr Health Sci. 2009 Sep;9(3):153-60
– reference: 16121199 - J Hum Hypertens. 2006 Jan;20(1):67-71
– reference: 16151443 - J Hum Hypertens. 2006 Jan;20(1):59-65
– reference: 16702826 - Blood Press Monit. 2006 Jun;11(3):165-71
– reference: 19038678 - J Am Coll Cardiol. 2008 Dec 2;52(23):1817-25
– reference: 19402221 - J Hypertens. 2009 May;27(5):963-75
– reference: 11234459 - World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
– reference: 22796254 - J Am Coll Cardiol. 2012 Aug 14;60(7):599-606
– reference: 15652604 - Lancet. 2005 Jan 15-21;365(9455):217-23
– reference: 10694181 - J Hypertens. 2000 Feb;18(2):145-52
SSID ssj0017852
Score 2.2984657
Snippet Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now...
Background Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension...
Doc number: 90 Abstract Background: Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and...
Background: Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 90
SubjectTerms Adolescent
Adult
Age Distribution
Angola
Angola - epidemiology
Awareness
Blood pressure
Cardiovascular diseases
Care and treatment
Chronic diseases
Disease
Economic growth
Epidemiology
Female
Field study
Follow-Up Studies
Health Knowledge, Attitudes, Practice
Health policy
Health risks
Humans
Hypertension
Hypertension - epidemiology
Hypertension - prevention & control
Hypertension - therapy
Male
Medical research
Medicine, Experimental
Middle Aged
Mortality
Physiological aspects
Population
Prevalence
Prevalence studies (Epidemiology)
Prevention
Public health
Risk Factors
Sex Distribution
Surveys
Tobacco
Tropical diseases
Young Adult
SummonAdditionalLinks – databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1di9QwcNDzRRDx2-opEQR9uHht89HGF1nEdRH0yYN7C0mTegeSXffu8O8702brVvCgT820TTPfmckMwOtoTFBoRnNdV5EjJ0ZuXCl5F7wilKPTRYeTv37TqxP55VSd5g23i5xWuZOJg6AO6472yI8rgYpXIbU0Hza_OHWNouhqbqFxE25VqGkopatdfp6iCE2r6lzOp2r1cYWCmNdSodskOAnhPU30rzzeU0jzZMk97bO8B3ez2cgWI57vw42YHsCdcc-NjUeJHoJboVO5HVLS14mdJzYEZeI2sUX6gS7se7bZUnVvYuYj5jJiYmC56Q7e-01nw1D4HbEpA525FFjOaH8EJ8tP3z-ueG6hwDvqVMCl9Dhz36gYtDGNQG8uauW8DE54r0VpgnFBdpUzQaPthtZXGfrQ1h7NFC-UeAwHaZ3iU2B9r_rQdL3TjZdOOK-i9rInD82rumsLeLdbTtvl-uLU5uKnHfyMVltaf0vrbythTVnA2-mBzVha4_-gbwg_lpgO39m5fHYAZ0blq-xCCalrKhVXwOEMEpmlmw_vMGwzs17Yv6RVwKtpmJ6kBLQU11cDDFIThXWvgyH7R-NVwJORaKYfq4XAD5SqgGZGThMAlfmej6Tzs6Hct1DGoNXw7PqpP4fb9dCpo0K1eggHl9ur-ALtpUv_cmCKP6vkFPA
  priority: 102
  providerName: ProQuest
Title Hypertension in Northern Angola: prevalence, associated factors, awareness, treatment and control
URI https://www.ncbi.nlm.nih.gov/pubmed/23363805
https://www.proquest.com/docview/1315956387
https://www.proquest.com/docview/1317850138
https://www.proquest.com/docview/1323816816
https://pubmed.ncbi.nlm.nih.gov/PMC3599429
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0fRFE_G60HisI-tDUJPuVFUSupechtEjx4PAl7GY3Wih7Nbao_70zm1zaSC2EfchOvmZndmays_Mj5JXX2glwo1NZ5D4FTfSpNhlPa2cFDjkEXbg5-fBIzhf801IsL-GAegb-vDa0QzypRXu6-_vHnw-g8O-jwpfybQ4TbFpwAeEQSzXE75tglhTCGRzyyyUFVUb4nYG4r_NzzQ1GJurfifqKpRpnUV4xS7P75F7vT9JpJwAPyC0fHpK73c842u0xekTMHKLNNuaqrwI9CTSu1vg20Gn4Bgx4R89aLPuNWr5DTT9i3tEejQfO_cJNYzAr7tAhNZ2a4Gif6v6YLGYHX_bnaY-tkNYIYZBybuHNrRLeSa0VgzDPS2Esd4ZZK1mmnTaO17nRToJTB25Z5hpXFhb8F8sEe0I2wir4LUKbRjRO1Y2RynLDjBVeWt5g6GZFUZcJ2V2zs6r7wuOIf3FaxQCklBXyv0L-VzmrdJaQN8MFZ13Njf-TvsbxqVA-4J616TcVwJthXatqKhiXBdaQS8j2iBK0qB53r0e4WgshPAKcPQEzlErIy6Ebr8TMtOBXF5EGJAvXe2-iQcdIwpGQp53QDB9WMAYPyERC1EicBgKs_z3uCSffYx1wJrQGd-LZzV_2nNwpIoRHDvZ2m2yctxf-BThS53ZCbqulgrbcz7GdfZyQzb2Do8_Hk_hrYhIVCNrjva9_Abv-HwQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELaq8gASQtwEChgJBA8NTXwlRkJoBSxbejy1Ut9cO3agEvIu21YVf4rfyEwuNkj0rVKe4sllz3wzE89ByMugtZdgRqeK5SEFSQyptplIK-8kLjk4XZicvLevZofi65E8WiO_-1wYDKvsMbEBaj-v8B_5Vs5B8UrgluLD4meKXaNwd7VvodGyxU74dQEu2-n77U-wvq8Ym34--DhLu64CaYXF-1MhXPCVK2TwSuuCg4MTlLROeMudUzzTXlsvqtxqr8CcAYMk87UvmQPN7ZouEQD51wQHTY6Z6dMvw65FUUrWlQ_KS7WVA_CnTEhw03iKoL-i-f7F_xUFOA7OXNF209vkVmem0knLV3fIWoh3yc32Hx9tU5fuETsDJ3bZhMDPIz2JtNkECstIJ_EbuMzv6GKJ1cQRPDap7RgheNo1-YFzF5iLBmC7SYeId2qjp10E_X1yeCWT-4Csx3kMjwita1n7oqqtKpyw3DoZlBM1eoROsqpMyNt-Ok3V1TPHtho_TOPXlMrg_Bucf5Nzo7OEvBkuWLSlPP5P-hrXx6CQwz0r2-UqwJthuSwzkVwohqXpErIxogThrMbD_QqbDhxOzV9WTsiLYRivxIC3GObnDQ1wE24jX0aD9paCIyEPW6YZPoxxDg_IZEKKETsNBFhWfDwST7435cW51BqslMeXv_pzcn12sLdrdrf3d56QG6zpEpKDSt8g62fL8_AUbLUz96wREEqOr1oi_wCJX1H2
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypertension+in+Northern+Angola%3A+prevalence%2C+associated+factors%2C+awareness%2C+treatment+and+control&rft.jtitle=BMC+public+health&rft.au=Pires%2C+Jo%C3%83%C2%A3o+E&rft.au=Sebasti%C3%83%C2%A3o%2C+Yuri+V&rft.au=Langa%2C+Ant%C3%B3nio+J&rft.au=Nery%2C+Susana+V&rft.date=2013-01-31&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2458&rft.eissn=1471-2458&rft.volume=13&rft_id=info:doi/10.1186%2F1471-2458-13-90&rft.externalDocID=A534624653
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon